BBNX vs JKHY · rev $100.3M vs P/E 30, rev $2.54B
Beta Bionics, Inc. Common Stock (BBNX) versus Jack Henry & Associates Inc (JKHY) — a side-by-side from cached financials, not a winner call.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
Jack Henry & Associates Inc (JKHY) is a information technology services company listed on US.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
Latest reported JKHY revenue for 2026-06-30 was $2.54B. Net income was $502.8M. Revenue was up 7.1% from 2025-06-30 to 2026-06-30. JKHY currently screens at market cap $12.76B and trailing P/E 29.8.
BBNX currently screens at market cap $640.8M. JKHY currently screens at market cap $12.76B and trailing P/E 29.8.
Not investment advice. Open the BBNX and JKHY stock pages for the full models.
Not investment advice.